Form 2a

This tutorial will guide you through evaluation form 2a. Evaluation form 2a is used for agents that are unlikely to be curative and where the clinical trial that led to its licensed indication either:

  • had a primary endpoint of overall survival, or  

  • had a primary endpoint of progression-free survival and a secondary endpoint of OS with mature data showing a significant OS benefit versus the control arm of the trial